This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. , Der Wissenschaft En E.v., Technical University of Munich. Active years: 2022-2026.
Company Filing History:
2 out of 1,327 
1 out of 1 
1 out of 151 
Years Active: 2022-2026
Title: Steffen Backert: Innovator in Infection Treatment
Introduction
Steffen Backert is a notable inventor based in Erlangen, Germany. He has made significant contributions to the field of medical science, particularly in the treatment of infections. His innovative work has led to the development of a patent that addresses critical health issues.
Latest Patents
Steffen Backert holds a patent titled "Methods for Treatment of Infections." This invention relates to inhibitors of the interaction between IIopQ and a member of the carcinoembryonic antigen-related cell adhesion molecule (CEACAM) family. The patent also includes immunogenic compositions based on HopQ. Furthermore, it discusses the use of these inhibitors and immunogenic compositions for preventing or treating diseases or disorders associated with infections.
Career Highlights
Throughout his career, Steffen Backert has been associated with prestigious organizations. He has worked with the Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. and Der Wissenschaft e.V. These experiences have enriched his expertise and contributed to his innovative endeavors.
Collaborations
Steffen has collaborated with talented individuals in his field, including Anahita Javaheri and Tobias Kruse. Their joint efforts have further advanced research and development in infection treatment.
Conclusion
Steffen Backert's contributions to the field of infection treatment through his innovative patent demonstrate his commitment to improving healthcare. His work continues to inspire advancements in medical science.